Carrier-Free Nano-Proteolysis Targeting Chimeras Enable Selective Protein Degradation and Enhance Photoimmunometabolic Therapy against Lung Adenocarcinoma

Journal:
ACS Nano
Published:
DOI:
10.1021/acsnano.5c21154
Affiliations:
3
Authors:
12
Go to article
Institutions Authors Share
Shandong First Medical University and Shandong Academy of Medical Sciences (SFMU), China
12.000000
12.000000
 1.00
Interested in Oncology and Carcinogenesis?